Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04322955
Title CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mark Stein
Indications

renal cell carcinoma

Therapies

Cabozantinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The Rutgers Cancer Institute of New Jersey Recruiting New Brunswick New Jersey 08903 United States Details
Columbia University Irving Medical Center Recruiting New York New York 10032 United States Details
Cleveland Clinic Recruiting Cleveland Ohio 44012 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field